Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Rising APAC Device MnA Demonstrates The Need For Regulatory Strategy

This article was originally published in SRA

Executive Summary

The number of M&A deals across Asia Pacific is increasing rapidly. But demonstration of product regulatory compliance is often not transferrable between APAC countries. How do you overcome this and other regulatory hurdles during your M&A deal-making? In this article, Ee Von Teo and Daniel Tan, together with their colleagues*, explain how to manage this dynamic new market opportunity. They also give a breakdown of the different medical device regulatory regimes in APAC and the transferability of registrations and licences by individual countries.

Advertisement
Advertisement
UsernamePublicRestriction

Register

MT040717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel